|
|
||||||||
1 Finnish Institute of Occupational Health, Dept of Occupational Medicine, and 2 Helsinki University Hospital, Laboratory of Clinical Physiology, Helsinki, Finland
CORRESPONDENCE: R. Piipari, Finnish Institute of Occupational Health, Topeliuksenkatu 41aA, FIN-00250, Helsinki, Finland. Fax: 358 94584761. E-mail: Ritva.Piipari@occuphealth.fi
Keywords: asthma, challenge tests, exhaled nitric oxide, occupational asthma
Received: May 21, 2002
Accepted July 13, 2002
Exhaled nitric oxide (NO) is a marker of eosinophilic inflammation of the airway mucosa accompanying changes in the clinical condition of asthma. Allergen exposure has been associated with delayed elevation of exhaled NO. The aim of this study was to assess the asthmatic airway inflammation with exhaled NO measurements during specific bronchial challenge tests with occupational agents.
Forty patients with suspected occupational asthma were investigated. Specific bronchial challenge tests were performed with forced expiratory volume in one second or peak expiratory flow follow-up, supplemented by exhaled NO measurements before and 24 h after challenge tests.
In active challenges, which induced bronchoconstriction, a significant mean increase of exhaled NO concentration was noted. In patients with a normal or slightly increased (<14.5 parts per billion (ppb)) basal NO level and a late bronchoconstriction, a significant increase in exhaled NO was seen. Patients with a high basal NO level (>14.5 ppb) and a significant bronchoconstriction did not show a significant NO elevation. Challenge tests without bronchoconstriction were not associated with a significant elevation of exhaled NO.
Exhaled nitric oxide measurements can be used to indicate the development of airway inflammation accompanying late asthmatic reaction after bronchial challenge tests in patients with a normal or slightly increased basal nitric oxide concentration.
This article has been cited by other articles:
![]() |
R. Kitz, M. A. Rose, A. Borgmann, R. Schubert, and S. Zielen Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects Innate Immunity, December 1, 2006; 12(6): 367 - 374. [Abstract] [PDF] |
||||
![]() |
S. M. Tarlo, J-L. Malo, and other Workshop members An ATS/ERS report: 100 key questions and needs in occupational asthma. Eur. Respir. J., March 1, 2006; 27(3): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Stark, J. T. Randell, M-R. Hirvonen, M. K. Purokivi, M. H. Roponen, and H. O. Tukiainen The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels Eur. Respir. J., November 1, 2005; 26(5): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Baur and L. Barbinova Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers Eur. Respir. J., February 1, 2005; 25(2): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |